Page last updated: 2024-09-04

canertinib and fluorouracil

canertinib has been researched along with fluorouracil in 2 studies

Compound Research Comparison

Studies
(canertinib)
Trials
(canertinib)
Recent Studies (post-2010)
(canertinib)
Studies
(fluorouracil)
Trials
(fluorouracil)
Recent Studies (post-2010) (fluorouracil)
12496545,5629,30714,663

Protein Interaction Comparison

ProteinTaxonomycanertinib (IC50)fluorouracil (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.32
Thymidylate synthaseMus musculus (house mouse)1.58
AromataseHomo sapiens (human)0.63

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aydinlik, S; Dere, E; Ulukaya, E1
Ju, WT; Liang, SY; Tang, X; Zhang, ZY; Zhao, TC; Zhong, LP; Zhou, ZH; Zhu, DW1

Other Studies

2 other study(ies) available for canertinib and fluorouracil

ArticleYear
Induction of autophagy enhances apoptotic cell death via epidermal growth factor receptor inhibition by canertinib in cervical cancer cells.
    Biochimica et biophysica acta. General subjects, 2019, Volume: 1863, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Fluorouracil; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Morpholines; Organometallic Compounds; Protein Kinase Inhibitors; Uterine Cervical Neoplasms

2019
Mechanism of sensitivity to cisplatin, docetaxel, and 5-fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression.
    Cancer science, 2022, Volume: 113, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cisplatin; Fluorouracil; Growth Differentiation Factor 15; Humans; Mice; Morpholines; Mouth Neoplasms; Phosphorylation; Receptor, ErbB-2; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Taxoids

2022